4D Molecular Therapeutics (FDMT)
(Delayed Data from NSDQ)
$9.97 USD
-0.37 (-3.58%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $9.99 +0.02 (0.20%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.67 | 0.00% |
Earnings Summary
For their last quarter, 4D Molecular Therapeutics (FDMT) reported earnings of -$0.63 per share, beating the Zacks Consensus Estimate of $-0.72 per share. This reflects a positive earnings surprise of 12.50%. Look out for FDMT's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.67 per share, reflecting a year-over-year decrease of 179.17%.
Earnings History
Price & Consensus
Zacks News for FDMT
Wall Street Analysts Think 4D Molecular Therapeutics (FDMT) Could Surge 225.1%: Read This Before Placing a Bet
FDMT: What are Zacks experts saying now?
Zacks Private Portfolio Services